AAT score based on pretreatment indicators predicts outcomes in unresectable HCC patients treated with TACE, Sintilimab, and Bevacizumab
-
By
-
Wanying Qin
-
Xudong Fei
-
Renfang Shi
-
Yuchen Zhou
-
Jiajie Tang
-
Yizhe Liu
-
Yi Zhu
-
Liya Suo
-
Weijia Liao
-
June 10, 2026
-
0 min
Top Institutions in Oncology
Brief introduction explaining scope and methodology.
-
#1
Affiliated Hospital of Guilin Medical University
Guilin, Guangxi
-
#2
Nanfang Hospital, Southern Medical University
Guangzhou, Guangdong
-
#3
The University of Texas Southwestern Medical Center
Dallas, Texas
-
#4
The First Affiliated Hospital of Jinan University
Jinan, Shandong
-
#5
Sun Yat-Sen University First Affiliated Hospital
Guangzhou, Guangdong
